Simcere Pharmaceutical Group Limited (2096.HK)

Healthcare | Biotechnology
Income Statement (Quarterly) 2026-04-09 2025-06-30 2025-03-31 2024-12-31
Revenue 3,584,912,000 3,584,912,000 1,792,456,000 1,760,843,500
Cost of Revenue 691,062,000 691,062,000 345,531,000 329,520,000
Gross Profit 2,893,850,000 2,893,850,000 1,446,925,000 1,431,323,500
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,615,564,000 1,615,564,000 807,782,000 822,832,000
Operating Expenses 2,209,204,000 2,209,204,000 1,104,602,000 1,253,380,000
Operating Income 684,646,000 684,646,000 342,323,000 177,943,500
Interest Expense 0 21,988,000 0 0
Income Before Tax 662,485,000 662,485,000 331,242,500 162,592,500
Income Tax Expense 58,878,000 58,878,000 29,439,000 24,310,000
Net Income 603,607,000 603,607,000 301,803,500 138,282,500
Per Share
EPS 0.24 0.24 0.12 0.06
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2023-06-30 2022-12-31 2021-12-31
Revenue 6,635,211,000 6,607,805,000 0 6,319,096,000 4,999,718,000
Cost of Revenue 1,310,632,000 1,623,652,000 0 1,322,246,000 1,079,983,000
Gross Profit 5,324,579,000 4,984,153,000 0 4,996,850,000 3,919,735,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 3,030,264,000 2,844,215,000 0 2,846,572,000 2,419,190,000
Operating Expenses 4,476,532,000 4,272,351,000 0 4,420,319,000 3,703,751,000
Operating Income 848,047,000 711,802,000 0 862,505,000 1,448,544,000
Interest Expense 69,557,000 34,568,000 0 34,408,000 70,848,000
Income Before Tax 819,878,000 740,038,000 0 888,154,000 1,401,797,000
Income Tax Expense 86,713,000 26,088,000 0 -40,478,000 -97,124,000
Net Income 733,165,000 714,761,000 0 932,768,000 1,507,096,000
Per Share
EPS 0.29 0.27 0.00 0.40 0.58
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 1,943,069,000 2,007,162,000 1,657,600,000 973,139,000
Short Term Investments 0 11,137,000 964,226,000 1,210,078,000
Net Receivables 2,710,068,000 2,644,645,000 2,337,443,000 0
Inventory 593,649,000 770,139,000 302,373,000 235,157,000
Total Current Assets 5,465,743,000 5,638,944,000 5,453,784,000 4,979,549,000
Property Plant Equipment 2,269,544,000 2,170,339,000 2,171,910,000 1,961,644,000
Goodwill and Intangibles 1,167,912,000 858,260,000 552,684,000 232,479,000
Total Assets 11,509,927,000 10,853,667,000 10,781,113,000 10,161,143,000
Liabilities
Account Payables 275,725,000 317,218,000 334,444,000 323,951,000
Short Term Debt 1,118,698,000 1,094,981,000 1,350,823,000 1,561,643,000
Total Current Liabilities 2,726,979,000 2,685,900,000 2,963,728,000 3,063,763,000
Long Term Debt 90,671,000 334,243,000 155,921,000 74,239,000
Total Liabilities 4,441,812,000 3,630,931,000 3,638,290,000 3,698,386,000
Shareholders Equity
Retained Earnings 0 3,837,325,000 3,061,248,000 0
Total Shareholders Equity 7,068,115,000 7,222,736,000 7,126,761,000 6,436,997,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 1,943,069,000 2,007,162,000 1,657,600,000 973,139,000 3,270,241,000
Short Term Investments 0 11,137,000 964,226,000 1,210,078,000 3,634,000
Net Receivables 2,710,068,000 2,644,645,000 2,337,443,000 0 0
Inventory 593,649,000 770,139,000 302,373,000 235,157,000 262,673,000
Total Current Assets 5,465,743,000 5,638,944,000 5,453,784,000 4,979,549,000 6,466,832,000
Property Plant Equipment 2,269,544,000 2,170,339,000 2,171,910,000 1,961,644,000 2,191,413,000
Goodwill and Intangibles 1,167,912,000 858,260,000 552,684,000 232,479,000 249,896,000
Total Assets 11,509,927,000 10,853,667,000 10,781,113,000 10,161,143,000 10,943,410,000
Liabilities
Account Payables 275,725,000 317,218,000 334,444,000 323,951,000 242,077,000
Short Term Debt 1,118,698,000 1,094,981,000 1,350,823,000 1,561,643,000 1,792,940,000
Total Current Liabilities 2,726,979,000 2,685,900,000 2,963,728,000 3,063,763,000 3,497,158,000
Long Term Debt 90,671,000 334,243,000 155,921,000 74,239,000 1,275,550,000
Total Liabilities 4,441,812,000 3,630,931,000 3,638,290,000 3,698,386,000 5,607,686,000
Shareholders Equity
Retained Earnings 0 3,837,325,000 3,061,248,000 0 0
Total Shareholders Equity 7,068,115,000 7,222,736,000 7,126,761,000 6,436,997,000 5,335,724,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income 819,878,000 740,038,000 888,154,000 1,507,096,000
Depreciation & Amortization 337,647,000 309,594,000 282,928,000 251,807,000
Stock Based Compensation 97,810,000 12,119,000 138,290,000 62,392,000
Change in Working Capital -81,557,000 -946,751,000 79,074,000 -769,246,000
Operating Cash Flow 1,391,116,000 151,048,000 1,354,712,000 -201,970,000
Investing Activities
Capital Expenditure -762,572,000 -979,855,000 -678,005,000 -209,488,000
Investments -356,972,000 -483,182,000 -678,005,000 -209,488,000
Investing Cash Flow -1,050,092,000 1,087,807,000 68,306,000 -435,503,000
Financing Activities
Debt Repayment -161,712,000 -151,071,000 -1,184,161,000 -2,463,778,000
Common Stock Issued/Repurchased -687,985,000 -289,073,000 0 0
Dividends Paid -401,484,000 -419,218,000 -391,296,000 -391,296,000
Financing Cash Flow -407,403,000 -894,834,000 -753,681,000 -1,624,531,000
Summary
Free Cash Flow 628,544,000 -828,807,000 676,707,000 -411,458,000
Net Change in Cash -64,093,000 348,850,000 684,461,000 -2,297,102,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income 819,878,000 740,038,000 888,154,000 1,507,096,000 669,534,000
Depreciation & Amortization 337,647,000 309,594,000 282,928,000 251,807,000 222,329,000
Stock Based Compensation 97,810,000 12,119,000 138,290,000 62,392,000 32,797,000
Change in Working Capital -81,557,000 -946,751,000 79,074,000 -769,246,000 -462,178,000
Operating Cash Flow 1,391,116,000 151,048,000 1,354,712,000 -201,970,000 96,731,000
Investing Activities
Capital Expenditure -762,572,000 -979,855,000 -678,005,000 -209,488,000 -352,841,000
Investments -356,972,000 -483,182,000 -678,005,000 -209,488,000 -352,841,000
Investing Cash Flow -1,050,092,000 1,087,807,000 68,306,000 -435,503,000 529,083,000
Financing Activities
Debt Repayment -161,712,000 -151,071,000 -1,184,161,000 -2,463,778,000 -1,824,871,000
Common Stock Issued/Repurchased -687,985,000 -289,073,000 0 0 3,007,932,000
Dividends Paid -401,484,000 -419,218,000 -391,296,000 -391,296,000 0
Financing Cash Flow -407,403,000 -894,834,000 -753,681,000 -1,624,531,000 2,353,622,000
Summary
Free Cash Flow 628,544,000 -828,807,000 676,707,000 -411,458,000 -256,110,000
Net Change in Cash -64,093,000 348,850,000 684,461,000 -2,297,102,000 2,915,437,000